Idera Pharmaceuticals, Inc. operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Idera Pharmaceuticals with three other
companies in this sector in the United States:
sales of $476,556.00
of which 100%
was Biological Product), and
AIM ImmunoTech Inc
During the year ended December of 2018, sales at
Idera Pharmaceuticals were $662,000.00 .
decrease of 26.6%
versus 2017, when the company's sales were $902,000.00 .